Our Approach
Developing novel, targeted neurotherapeutics offers a transformative approach to treating psychiatric and neurological disorders. By harnessing the brain's ability to rewire and restore function, we can address underlying dysfunctions instead of managing symptoms, paving the way for long-term recovery.
Precision Neurotherapeutics
At Xylo, we combine world-class expertise in medicinal chemistry with cutting-edge computational drug discovery to develop a novel class of small molecules designed and optimized to target specific receptors that promote neuroplasticity while avoiding mechanisms linked to undesirable effects that restrict patient access.
Breakthrough Treatments
Our goal is to deliver transformative therapies that integrate seamlessly into existing healthcare systems, making these innovations accessible to a greater number of patients in need.
Development Pipeline
.webp)